# FDA 483 - LifeShare Blood Center - November 19, 2019

Source: https://www.globalkeysolutions.net/records/483/lifeshare-blood-center/d9e82d49-dae0-452d-9f89-007c47f7e238

> FDA 483 for LifeShare Blood Center on November 19, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: LifeShare Blood Center
- Inspection Date: 2019-11-19
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: An FDA inspection of LifeShare Blood Center in Bossier City, LA, revealed significant deficiencies in quality control and record-keeping at its donor center. Observations included failures to maintain donor adverse reaction reports, conduct thorough investigations into discrepancies like temperature excursions, properly store critical supplies after a water leak, and adequately clean and maintain blood collection equipment. These issues indicate a lack of adherence to established procedures and regulatory requirements for blood product collection and handling.

## Related Officers

- [Regulatory Project Manager](https://www.globalkeysolutions.net/people/nimmy-mathews/9eac44d1-5e4c-493a-89c5-c7414a5a4037)

Company: https://www.globalkeysolutions.net/companies/lifeshare-blood-center/e1707c60-8e43-4429-b543-0a9e2e85cdc6

Office: https://www.globalkeysolutions.net/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea